Skip to content

Comparison of Low and High Tidal Volumes in Acute Spinal Cord Injury

Comparison of Mechanical Ventilation With Low and High Tidal Volumes in Acute Spinal Cord Injury: A Pilot Randomized Comparative Effectiveness Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04912583
Enrollment
31
Registered
2021-06-03
Start date
2021-12-17
Completion date
2024-06-27
Last updated
2025-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Keywords

Spinal cord injury, Mechanical ventilation, Pneumonia, Tidal volume

Brief summary

Objective: This study's primary objective is to evaluate the efficacy and feasibility of mechanical ventilation with high vs. low tidal volume (Vt) in people with acute spinal cord injury (SCI). Secondary objectives include a comparison of inflammatory markers between these groups. Study Design: Randomized comparative effectiveness trial Methods: Study population: Adults with acute traumatic SCI on mechanical ventilation (MV). Subjects will be randomized to receive either a lower Vt of 8-10 cc/kg predicted body weight (pbw) or a high Vt of 14-16 ml/kg pbw. Risks and potential Benefits: Risks of study interventions are similar to usual care as proposed tidal volume settings are within the current usual care range. However, people assigned to the lower tidal volume group may have a lower risk of pneumonia and respiratory complications.

Detailed description

Background: Respiratory complications associated with mechanical ventilation (MV) are the leading cause of morbidity and mortality following acute spinal cord injury (SCI). Emerging evidence suggests pneumonia is also associated with reduced neurologic recovery. Therefore, pneumonia prevention is of primary importance to improve outcomes. In the non-SCI population, MV with lower tidal volume (Vt) has been shown to reduce inflammation and rates of pneumonia. High Vt MV results in disruption of pulmonary endothelium and release of inflammatory mediators, which play a role in the development of pulmonary complications. In contrast, guidelines for SCI practitioners recommend MV with higher Vt without strong evidence. Objective: The primary objective of this study is to evaluate the feasibility of conducting a randomized control trial comparing MV with high vs. low Vt. Secondary objectives include a comparison of clinical outcomes and inflammatory mediators between these groups. Methods: Study population: Adults with acute traumatic SCI admitted to an acute inpatient rehabilitation facility on MV. Subjects will be randomized to receive either a lower Vt of 8-10 cc/kg predicted body weight (pbw) or a high Vt of 14-16 ml/kg pbw. Study participants will be randomly assigned to high tidal volume (14-16 ml/kg pbw) or low tidal volume of 8 to 10 ml/kg pbw within 48 hrs of admission, stratified based on vital capacity at admission to ensure equal allocation of those with most severe respiratory impairment and unlikely to wean from the vent. Importance of knowledge gained from the study: Investigators believe the completion of this study will add to the fund of knowledge of respiratory management of people with SCI, especially at the early stages of the injury, including reducing respiratory complications in people with SCI who are at very high risk of severe respiratory complications which is the main cause of morbidity and mortality in this population.

Interventions

A high tidal volume (14-16 ml/kg pbw) with positive end-expiratory pressure will be applied during mechanical ventilation.

A low tidal volume (8-10 ml/kg pbw) with positive end-expiratory pressure will be applied during mechanical ventilation.

Sponsors

TIRR Memorial Hermann
CollaboratorOTHER
Craig Hospital
CollaboratorOTHER
National Center for Advancing Translational Sciences (NCATS)
CollaboratorNIH
The Craig H. Neilsen Foundation
CollaboratorOTHER
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Participants, principal investigator, outcome assessors, and statistician will be blinded to tidal volume assignment.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients ≥ 18 years (Lung volumes and ventilator settings are different for ages \<18 years). * Acute SCI of duration ≤ four months * Mechanical ventilation subjects: traumatic or non-traumatic cervical SCI with neurological level C1-C5 admitted to our acute inpatient rehabilitation facility (AIR) on mechanical ventilation

Exclusion criteria

* Severe dysphagia due to concomitant brain stem injury, which increases the risk of pneumonia * Severe brain injury resulting in dysphagia and inability to follow instructions to perform vital capacity measurements * ARDS or severe lung disease (required supplemental oxygen or ventilator prior to SCI) at the time of admission (these conditions will not allow patients to randomize because target vt may below) * Prolonged antibiotics for \> 3 weeks at the time of admission due to infection (e.g., osteomyelitis, epidural abscess, etc.), * Presence of diaphragmatic pacemaker.

Design outcomes

Primary

MeasureTime frameDescription
Number of Episodes of PneumoniaFrom the time of enrollment to time of discharge from hospital (about 6 weeks)The primary outcome is pneumonia episodes with evidence of new or progressive and persistent infiltrate on chest radiograph plus 2 of the following abnormal white blood cell count, presence of fever or hyperthermia, purulent sputum, and deterioration in gas exchange. Any new pneumonia episodes which meet the above criteria and developed 48 hours after achieving target tidal volume will be recorded.

Secondary

MeasureTime frameDescription
Feasibility as Assessed by Recruitment RateAt the time of consent (within 48 hours of hospital admission)Recruitment rate is the proportion of eligible people who provide consent.
Feasibility as Assessed by Adherence RateAt the time of start of intervention (within 48 hours of hospital admission)Adherence rate is the proportion of participants in each group who receive the assigned intervention per protocol.
Feasibility as Assessed by Retention Rateat the time of discharge from hospital (about 6 weeks after admission)Retention rate is the number of participants in each group who complete all study procedures.
Feasibility as Assessed by Number of Participants With Missing DataFrom the time of enrollment to time of discharge from hospital (about 6 weeks)

Other

MeasureTime frameDescription
Number of Respiratory ComplicationsFrom the time of enrollment to the time of discharge from the hospital (about 6 weeks)The following ventilator-associated events will be reported: transfer to acute care hospital due to respiratory complications, weaning failure, new pneumothorax, Acute respiratory distress syndrome (ARDS), pleural effusion, pulmonary embolism, atelectasis, and pulmonary edema.

Countries

United States

Participant flow

Pre-assignment details

A total of 62 participants were screened for eligibility. Of those, 31 met the inclusion criteria and signed informed consent. One participant was transferred before randomization and did not continue in the study. A total of 31 participants were enrolled, and 30 were randomized.

Participants by arm

ArmCount
Low Tidal Volume
A low tidal volume (8-10 ml/kg pbw) with positive end-expiratory pressure will be applied during mechanical ventilation. Low tidal volume: A low tidal volume (8-10 ml/kg pbw) with positive end-expiratory pressure will be applied during mechanical ventilation.
15
High Tidal Volume
A high tidal volume (14-16 ml/kg pbw) with positive end-expiratory pressure will be applied during mechanical ventilation. High tidal volume: A high tidal volume (14-16 ml/kg pbw) with positive end-expiratory pressure will be applied during mechanical ventilation.
15
Total30

Baseline characteristics

CharacteristicLow Tidal VolumeHigh Tidal VolumeTotal
Age, Continuous54 years
STANDARD_DEVIATION 13
44 years
STANDARD_DEVIATION 17
49 years
STANDARD_DEVIATION 15.13
Asia Impairment Scale Classification
A
9 Participants11 Participants20 Participants
Asia Impairment Scale Classification
B
5 Participants2 Participants7 Participants
Asia Impairment Scale Classification
C
1 Participants2 Participants3 Participants
Asia Impairment Scale Classification
D
0 Participants0 Participants0 Participants
Cause of injury
Fall
4 Participants3 Participants7 Participants
Cause of injury
Medical/Surgical Complications
1 Participants0 Participants1 Participants
Cause of injury
Other traumatic Injuries
0 Participants1 Participants1 Participants
Cause of injury
Sports
1 Participants3 Participants4 Participants
Cause of injury
Vehicular
8 Participants7 Participants15 Participants
Cause of injury
Violence
1 Participants1 Participants2 Participants
Neurological Level of Spinal Cord Injury (SCI)
C1 to C3
7 Participants9 Participants16 Participants
Neurological Level of Spinal Cord Injury (SCI)
C4 to C5
8 Participants6 Participants14 Participants
Number of participants with a history of concomitant mild traumatic brain injury or stroke5 Participants2 Participants7 Participants
Number of participants with a history of lung or pulmonary disorders prior to Spinal Cord Injury0 Participants1 Participants1 Participants
Number of Participants with a smoking history5 Participants3 Participants8 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Asian
1 Participants1 Participants2 Participants
Race (NIH/OMB)
Black or African American
3 Participants1 Participants4 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants2 Participants3 Participants
Race (NIH/OMB)
White
10 Participants10 Participants20 Participants
Region of Enrollment
United States
15 participants15 participants30 participants
Sex: Female, Male
Female
2 Participants4 Participants6 Participants
Sex: Female, Male
Male
13 Participants11 Participants24 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 151 / 15
other
Total, other adverse events
12 / 1512 / 15
serious
Total, serious adverse events
0 / 151 / 15

Outcome results

Primary

Number of Episodes of Pneumonia

The primary outcome is pneumonia episodes with evidence of new or progressive and persistent infiltrate on chest radiograph plus 2 of the following abnormal white blood cell count, presence of fever or hyperthermia, purulent sputum, and deterioration in gas exchange. Any new pneumonia episodes which meet the above criteria and developed 48 hours after achieving target tidal volume will be recorded.

Time frame: From the time of enrollment to time of discharge from hospital (about 6 weeks)

ArmMeasureValue (MEAN)Dispersion
High Tidal VolumeNumber of Episodes of Pneumonia.13 episodes of pneumoniaStandard Deviation 0.35
Low Tidal VolumeNumber of Episodes of Pneumonia.4 episodes of pneumoniaStandard Deviation 0.5
Secondary

Feasibility as Assessed by Adherence Rate

Adherence rate is the proportion of participants in each group who receive the assigned intervention per protocol.

Time frame: At the time of start of intervention (within 48 hours of hospital admission)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
High Tidal VolumeFeasibility as Assessed by Adherence Rate11 Participants
Low Tidal VolumeFeasibility as Assessed by Adherence Rate13 Participants
Secondary

Feasibility as Assessed by Number of Participants With Missing Data

Time frame: From the time of enrollment to time of discharge from hospital (about 6 weeks)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
High Tidal VolumeFeasibility as Assessed by Number of Participants With Missing Data0 Participants
Low Tidal VolumeFeasibility as Assessed by Number of Participants With Missing Data0 Participants
Secondary

Feasibility as Assessed by Recruitment Rate

Recruitment rate is the proportion of eligible people who provide consent.

Time frame: At the time of consent (within 48 hours of hospital admission)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
High Tidal VolumeFeasibility as Assessed by Recruitment Rate31 Participants
Secondary

Feasibility as Assessed by Retention Rate

Retention rate is the number of participants in each group who complete all study procedures.

Time frame: at the time of discharge from hospital (about 6 weeks after admission)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
High Tidal VolumeFeasibility as Assessed by Retention Rate15 Participants
Low Tidal VolumeFeasibility as Assessed by Retention Rate15 Participants
Other Pre-specified

Number of Respiratory Complications

The following ventilator-associated events will be reported: transfer to acute care hospital due to respiratory complications, weaning failure, new pneumothorax, Acute respiratory distress syndrome (ARDS), pleural effusion, pulmonary embolism, atelectasis, and pulmonary edema.

Time frame: From the time of enrollment to the time of discharge from the hospital (about 6 weeks)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026